Supplementary Figure S2 from Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study
Authors:
- Samantha I. LiangSLSamantha I. Liang
- Zoe QuandtZQZoe Quandt
- Sara WienkeSWSara Wienke
- Jing WangJWJing Wang
- Sean GordonSGSean Gordon
- Reagan M. BarnettRBReagan M. Barnett
- Jude MasannatJMJude Masannat
- Kyle ChangKCKyle Chang
- Carin R. EspenschiedCECarin R. Espenschied
- Katie J. QuinnKQKatie J. Quinn
- Kimberly C. BanksKBKimberly C. Banks
- Enjun YangEYEnjun Yang
Open Access
- 20 August 2025
- other
- Published by American Association for Cancer Research (AACR)